A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease. By Rebecca Robbins and Gina Kolata A ...
A methodology to create efficient manufacturing mixed-signal tests that reduce both test costs and test escapes.